We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01401374
Recruitment Status : Completed
First Posted : July 25, 2011
Last Update Posted : April 10, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Condition or disease
Vitiligo Vulgaris

Detailed Description:
The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.

Study Design

Study Type : Observational
Actual Enrollment : 3258 participants
Observational Model: Other
Time Perspective: Other
Official Title: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
Study Start Date : March 2011
Primary Completion Date : March 2016
Study Completion Date : March 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitiligo
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Vitiligo Patients
patients with vitiligo vulgaris
Controls
Individuals without vitiligo vulgaris


Outcome Measures

Primary Outcome Measures :
  1. Correlation of Disease State in Vitiligo with Clinical and Psychological Measures [ Time Frame: Self-reported retrospective single survey ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris
Criteria

Inclusion Criteria:

  • Ability to complete survey

Exclusion Criteria:

  • Inability to complete survey
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01401374


Locations
United States, New York
St. Luke's-Roosevelt Hospital Center
New york, New York, United States, 10025
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Nanette Silverberg, MD St. Luke's-Roosevelt Hospital Center
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier: NCT01401374     History of Changes
Other Study ID Numbers: 10-148/10-149x
First Posted: July 25, 2011    Key Record Dates
Last Update Posted: April 10, 2017
Last Verified: April 2017

Keywords provided by St. Luke's-Roosevelt Hospital Center:
Vitiligo Vulgaris
Autoimmunity
Thyroid Disease

Additional relevant MeSH terms:
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases